Biofil Chemicals & Pharmaceuticals share news, announcements and annual reports
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Biofil Chemicals & Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Jun 1996 on NSE
Last close ₹28.68down ₹0.73 (2.48%)BSE ₹29.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.41.
30 Oct: open ₹29.00, high ₹29.80, low ₹28.26
52-week range of traded prices to 30 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 96.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,71974.4% delivered
Biofil Chemicals & Pharmaceuticals results
69 filed, newest first. Page 2 of 2.
Feb 2015
Nov 2014
Aug 2014
May 2014
30 May · Results
Feb 2014
11 Feb · Results
Dec 2013
11 Dec · Results
Aug 2013
Feb 2013
Nov 2012
Aug 2012
14 Aug · Results
May 2012
29 May · Results
Feb 2012
Nov 2011
Feb 2011
Nov 2010
Apr 2009
20 Apr · Results
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board has decided to submit/ publish the Audited Financial Results for the year ended on March 31, 2009 with in the prescribed time limit stipulated in the listing agreement.
Apr 2008
24 Apr · Results
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange: "Board has decided to submit / publish the Audited Financial Results for the year ended on 31st March, 2008 with in the prescribed time limit stipulated in the listing agreement and the same will be submitted to you with in the prescribed time limit."
Feb 2008
1 Feb · Results
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Board of the Directors of the Company as its meeting held January 31, 2008 has announced the result for postal ballot through which the shareholders of the Company have passed an ordinary resolution to authorize the Board of Directors to sell the unit situated at the Sanwer Road, Indore in terms of section 293 (1) (a) read with section 192A of the Companies Act, 1956". Further the Company has submitted a copy of scrutinizer report. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2007
22 May · Results
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Company shall publish Audited Financial Results within a period of 3 month for the year ended on March 31, 2007 i.e. on or before June 30, 2007.